Sign Up Today and Learn More About Chime Biologics Stock
Invest in or calculate the value of your shares in Chime Biologics or other pre-IPO companies through EquityZen's platform.
Chime Biologics Stock (CHBI)
Chime Biologics is a biopharmaceutical development and manufacturing company.
About Chime Biologics Stock
Founded
2013
Industries
Software, Artificial Intelligence, Data and Analytics
Chime Biologics Press Mentions
Stay in the know about the latest news on Chime Biologics
Chime and Polpharma strike deal on global biosimilar development
thepharmaletter • Apr 17, 2025
Chime Biologics Partners Polpharma Biologics to Advance Global Biosimilar Development
prnewswire • Apr 16, 2025
Chime Biologics Supports Mabgeek to Enter the U.S. Phase III Trials for MG-K10
prnewswire • Feb 21, 2025
Chime Biologics Supports Mabgeek to Enter the U.S. Phase III Trials for MG-K10
en • Feb 21, 2025
Chime Biologics Supports Mabgeek to Enter the U.S. Phase III Trials for MG-K10
morningstar • Feb 21, 2025
Chime Biologics Management
Leadership team at Chime Biologics
CEO
John (Xianfang) Zeng
Chairman and Board Director
Andrew Ng
Join now and verify your accreditation status to gain access to:
- Chime Biologics Current Valuation
- Chime Biologics Stock Price
- Chime Biologics Management
- Available deals in Chime Biologics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Chime Biologics Cap Table and Funding History by Share Class and Liquidity Preferences
- Chime Biologics Revenue and Financials
- Chime Biologics Highlights
- Chime Biologics Business Model
- Chime Biologics Risk Factors
- Chime Biologics Research Report from SACRA Research
Trading Chime Biologics Stock
How to invest in Chime Biologics stock?
Accredited investors can buy pre-IPO stock in companies like Chime Biologics through EquityZen funds. These investments are made available by existing Chime Biologics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Chime Biologics stock?
Shareholders can sell their Chime Biologics stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
